Capstone Investment Advisors, LLC Bio N Tech Se Transaction History
Capstone Investment Advisors, LLC
- $38.9 Billion
- Q4 2024
A detailed history of Capstone Investment Advisors, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Capstone Investment Advisors, LLC holds 2,767 shares of BNTX stock, worth $332,067. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,767
Previous 6,541
57.7%
Holding current value
$332,067
Previous $776,000
59.41%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding BNTX
# of Institutions
363Shares Held
39.6MCall Options Held
3.01MPut Options Held
2.01M-
Baillie Gifford & CO8.22MShares$987 Million0.74% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.41MShares$529 Million2.03% of portfolio
-
Primecap Management CO Pasadena, CA4.3MShares$516 Million0.39% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$227 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$217 Million1.03% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $29.1B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...